Adalidsciences
1 known investors
Adalid Sciences develops next-generation lipid nanoparticles (LNPs) for gene delivery, including proprietary ionizable lipids, lipid-polymer conjugates, and customizable, PEG-free compositions. Its technology targets therapeutic applications such as mRNA protein replacement therapies, mRNA vaccines, RNAi therapeutics, gene editing, and T-cell therapeutics, serving pharma, biotech startups, and CDMOs.
Founders & leadership
KG
Klara Grantz SaskovaCEO
Investors · 1
Frequently asked questions
- What does Adalidsciences do?
- Adalid Sciences develops next-generation lipid nanoparticles (LNPs) for gene delivery, including proprietary ionizable lipids, lipid-polymer conjugates, and customizable, PEG-free compositions. Its technology targets therapeutic applications such as mRNA protein replacement therapies, mRNA vaccines, RNAi therapeutics, gene editing, and T-cell therapeutics, serving pharma, biotech startups, and CDMOs.
- Who are Adalidsciences's investors?
- Adalidsciences's investors include Biotech Investments S.R.O.